XEOMIN offers patients A DURABLE NEUROTOXIN
AS RESILIENT AS THEY ARE
Designed with Purity in mind, XEOMIN contains only the active neurotoxin
Over time, repeated exposure to therapeutic proteins can contribute to a decrease in treatment response. XEOMIN is developed using proprietary XTRACT Technology® manufacturing process that removes the complexing proteins.
What can waning efficacy look or sound like?
Decreased Satisfaction1
Patients say the drug doesn't work as well as it used toIncreased Dosing1
Patients appear to require an increased dose in order to maintain efficacy or regain lost efficacyHigher Frequency1
Patients are requesting shorter dosing intervals because they are experiencing decreased responseLoss of Patients
Patients feel less motivated to come back for reinjection or are lost to follow-upAdministering XEOMIN
Reconstitution to Flip For
Prepare XEOMIN for injection in 3
straightforward steps.
Learn to
straightforward steps.
Reconstitute XEOMIN

Merz has your back
Reimbursement
Offering comprehensive support services for your patients.
Get Support with Merz Connect
XEOMIN is broadly covered
for FDA-approved indications with Top National Payers
Learn More

Stay in Fighting Shape
Request a Rep*First line indicates no step therapy is required for XEOMIN patients if they meet clinical eligibility requirements as defined by each payer policy.
References
- Carr WW, Jain N, Sublett JW. Immunogenicity of botulinum toxin formulations: potential therapeutic implications. Adv Ther. 2021;38(10):5046-5064.